Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation

Atrial fibrillation (AF) is associated with an increased risk of thromboembolism, and is the most prevalent factor for cardioembolic stroke. Vitamin K antagonists (VKAs) have been the standard of care for stroke prevention in patients with AF since the early 1990s. They are very effective for the pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Huber, K, Connolly, S J, Kher, A, Christory, F, Dan, G-A, Hatala, R, Kiss, R G, Meier, B, Merkely, B, Pieske, B, Potpara, T, Stępińska, J, Klun, N Vene, Vinereanu, D, Widimský, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Cardiovascular
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712459/
https://www.ncbi.nlm.nih.gov/pubmed/23557519
http://dx.doi.org/10.1111/ijcp.12147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712459/
https://www.ncbi.nlm.nih.gov/pubmed/23557519
http://dx.doi.org/10.1111/ijcp.12147

Ejemplares similares